Filing Details

Accession Number:
0001144204-19-039191
Form Type:
4
Zero Holdings:
No
Publication Time:
2019-08-12 16:19:44
Reporting Period:
2019-08-08
Accepted Time:
2019-08-12 16:19:44
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1644963 Avenue Therapeutics Inc. ATXI Pharmaceutical Preparations (2834) 474113275
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1715291 Walter Joseph Vazzano C/O Avenue Therapeutics, Inc.
2 Gansevoort Street, 9Th Floor
New York NY 10014
Chief Financial Officer No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Disposition 2019-08-08 2,313 $5.62 59,038 No 4 S Direct
Common Stock Disposition 2019-08-09 2,375 $5.56 56,663 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Direct
No 4 S Direct
Footnotes
  1. On August 8, 2019, a total of 2,313 shares were sold by the Company at a weighted average sales price of $5.62 in order to satisfy the reporting person's tax withholding obligations. The reporting person had no discretion with respect to such sale, which was conducted automatically in accordance with the issuer's corporate policies.
  2. On August 9, 2019, a total of 2,375 shares were sold by the Company at a weighted average sales price of $5.56 in order to satisfy the reporting person's tax withholding obligations. The reporting person had no discretion with respect to such sale, which was conducted automatically in accordance with the issuer's corporate policies.